David Colquhoun

Last updated

David Colquhoun

FRS MAE
David Colquhoun-1b.jpg
David Colquhoun in 2013
Born (1936-07-19) 19 July 1936 (age 87) [1]
Birkenhead, Cheshire, England
Alma mater
Known for
Awards Humboldt Prize (1990)
Scientific career
Fields
Institutions
Thesis The characterisation and adsorption of sensitising antibodies  (1965)
Doctoral advisor W.L.M. Perry
W.E. Brocklehurst[ citation needed ]
Website dcscience.net

David Colquhoun FRS MAE (born 19 July 1936) is a British pharmacologist at University College London (UCL). [5] He has contributed to the general theory of receptor and synaptic mechanisms, and in particular the theory and practice of single ion channel function. He held the A.J. Clark chair of Pharmacology at UCL from 1985 to 2004, and was the Hon. Director of the Wellcome Laboratory for Molecular Pharmacology. He was elected a Fellow of the Royal Society (FRS) in 1985 [6] and an honorary fellow of UCL in 2004. Colquhoun runs the website DC's Improbable Science, [2] which is critical of pseudoscience, particularly alternative medicine, and managerialism. [4]

Contents

Early life and education

Colquhoun was born on 19 July 1936 in Birkenhead, UK. [1] He was educated at Birkenhead School and Liverpool Technical College. After working unhappily as an apprentice pharmacist, he was motivated to go into research. [7] He obtained a BSc from the University of Leeds with a specialisation in pharmacology, and went on to complete a PhD at the University of Edinburgh [8] where he studied the binding of immunoglobulins to lung tissue. His supervisors were Walter Perry and W.E. Brocklehurst. During his education, Colquhoun developed an interest in statistics and random processes, which would influence his research in years to come.

Upon completion of his PhD, Colquhoun conducted further research (largely unsuccessful) on immunological problems at UCL from 1964 to 1969. During this time he published a book on statistics. [9] Following this, he completed stints at Yale University and at the University of Southampton. [7] He returned to the pharmacology department at UCL in 1979, where he has remained since. In 2007, Malcolm Grant brought an end to the department, ending its eminent 102-year history (see Department of Pharmacology at University College London, 1905 – 2007).

Scientific career

Colquhoun researched the nature of the molecular interactions that cause single ion channels to open and shut, and what it is that controls the speed of synaptic events. The invention and successful application of the patch clamp technique by Erwin Neher and Bert Sakmann allowed the individual openings and closings of single ion channels to be observed and recorded. However, experimentally observed recordings are random in nature. [10] With the help of the statistician Alan G. Hawkes, Colquhoun developed a statistical method to interpret the data and test putative quantitative mechanisms for how ion channels function. [11]

Work with single ion channels

Course mug design for the Department of Pharmacology at UCL Mug-2007.jpg
Course mug design for the Department of Pharmacology at UCL

In 1977 Colquhoun and Hawkes [12] predicted that ion channel openings would be expected to occur in brief bursts rather than as single openings, and this prediction was verified in experiments with Bert Sakmann, in Göttingen and London (1981). [13] [14] This work led to the first solution of the classical pharmacological problem of measuring separately the affinity and efficacy of an agonist. [15] In the context of ion channels, this problem is also known as the binding/gating problem. This problem remains unsolved for G protein-coupled receptors, because it was shown in 1987 that the classical methods for determining affinity and efficacy were based on a misapprehension. [16]

The 1985 paper was later nominated as a "classic" [17] by The Journal of Physiology . [18] In 1982 Colquhoun & Hawkes published a paper [19] on the theory of bursts (and clusters of bursts) which gave a general expression for the distribution of the burst length (shown here on the design for a mug for those who attend a course designed to teach the mathematics needed for the equation). [20]

It was clear that the burst length was what controlled the decay rate of synaptic currents, though the formal relationship was not derived until 1998. [21]

Missed short events

Although the general theory of single channel behaviour was completed in 1982, it could not be used in practice for fitting mechanisms to data, because the recording apparatus is incapable of detecting events shorter than, at best, about 20 microseconds. The effect of missing short shuttings is to make openings appear to be longer than they really are (and likewise for shuttings). To use the method of maximum likelihood it was essential to derive the distribution of the length of what is actually seen, apparent open times and apparent shut times. Although the Laplace transform of these distributions was known, it was thought that they were not invertible until Hawkes and Jalali found an exact solution in 1990. [22] The exact solution was a piecewise expression that got progressively more complicated as the length of the opening (or shutting) increased. The solution became usable in practice after Hawkes and Jalali discovered an elegant asymptotic solution in 1992. [23] The application of the exact solution to joint and conditional distributions in 1996 [24] opened the door to maximum likelihood fitting, which was implemented in a computer program, HJCFIT, [25] which has been the basis of subsequent experimental work. The distributions of apparent open and shut times are often referred to as HJC distributions (for Hawkes, Jalali, Colquhoun). [11]

Intermediate shut states

All the early work was based on mechanisms that were essentially generalisations of the simple scheme proposed by del Castillo & Katz in 1957, [26] in which the receptor existed in only two conformations, open and shut. It was only when the glycine receptor was investigated that it was realised that it was possible to detect an intermediate shut state (dubbed the "flipped" conformation), between the resting conformation and the open state. [27] Subsequently, it was discovered that this extra "flipped" conformation was detectable too in the nicotinic acetylcholine receptor. Lape et al. (2008) [28] found that partial agonists were partial, not, as had been supposed since 1957, because of a deficiency in the open reaction itself, but because of a deficiency at an earlier stage, a reluctance to move from the resting conformation to the intermediate shut state that precedes opening. The actual shut-open conformation change turned out to be much the same for partial agonists as it was for full agonists. In the original formulation the flipping reaction was supposed to be a concerted transition. The essentials of this new mechanism were confirmed by Mukhtasimova et al. (2009), [29] who generalised it to the case where the subunits can flip independently.

Statistical inference

After retiring from single ion channel work, Colquhoun maintained an interest in statistical inference. His 2014 paper, An investigation of the false discovery rate and the misinterpretation of p-values, [30] contributed to the p-value debate, and to the discussion of reproducibility in science. This paper has been followed by others which have explored the basis of inductive inference, [31] and which have investigated in more depth the alternatives to using p values. [32] [3] The hazards of reliance on p-values was emphasised in [32] by pointing out that even observation of p = 0.001 was not necessarily strong evidence against the null hypothesis. Despite the fact that the likelihood ratio in favour of the alternative hypothesis over the null is close to 100, if the hypothesis was implausible, with a prior probability of a real effect being 0.1, even the observation of p = 0.001 would have a false positive risk of 8 percent. It would not even reach the 5 percent level. It was recommended that the terms "significant" and "non-significant" should not be used. P values and confidence intervals should still be specified, but they should be accompanied by and indication of the false positive risk. It was suggested that the best way to do this is to calculate the prior probability that would it would be necessary to believe in order to achieve a false positive risk of, say, 5%. Or, perhaps more simply, the p value could be supplemented by the minimum false positive risk, FPR50, -that calculated for a prior probability of 0.5. [3] Although this would be safe only for plausible hypotheses, it would be a great improvement on giving on p values and confidence intervals. The calculations can be done with R scripts that are provided, [32] [3] or, more simply, with a web calculator. [33]

Criticism of scientific fraud, alternative medicine and managerialism

Colquhoun has been an outspoken critic of pseudoscience and scientific fraud for many years. He has written extensively on the topic, including articles and letters in Nature [34] [35] [36] and The Guardian . [37] He is particularly critical of alternative medicine, and of the decision of a number of UK universities to offer science degrees incorporating courses in complementary and alternative medicine such as homoeopathy and acupuncture. [34] stating that they are "anti-science" and that "universities that run them should be ashamed of themselves." [38] His interest in inference extends to methods that are used to assess and manage science, and critical assessment of research "metrics". [39] In December 2009, Colquhoun won a Freedom of Information judgement, after a three-year campaign, requiring the University of Central Lancashire to release details of their BSc course in homoeopathy. [40] [41]

DC's Improbable Science website

Colquhoun created his personal website, DC's Improbable Science, [2] devoted to criticism of pseudoscience, in 2001. It has a particular focus on alternative medicine (AM), including such practices as homoeopathy, Traditional Chinese medicine, herbal medicine, and others, calling them "pure gobbledygook". In addition to his outspoken disapproval of AM in academia, Colquhoun frequently speaks out on his website against misrepresentation of AM as science in the media, and against governmental support of AM. His blog discusses also wider problems in science, medicine and higher education. It was listed among the 100 best blogs in 2009. [42] It was blog of the week in the New Statesman (30 May 2010). And in 2012 it was co-winner of the first UK Science Blog Prize, awarded by the Good Thinking Society. [43] The most-read post on his blog is not related to alternative medicine however, instead dealing with the death of Stefan Grimm: "Publish and perish at Imperial College London: the death of Stefan Grimm", [44] which has been viewed more than 200,000 times.

Controversy over website hosting

In May 2007, Colquhoun announced on his website that recent comments he had made questioning the validity of claims made by Ann Walker, a lecturer in Nutrition at the University of Reading and a herbalist, had resulted in a complaint to Malcolm Grant, provost of UCL. [45] In response to legal threats from Alan Lakin, husband of Walker, Grant required Colquhoun to remove his website from the UCL server. This resulted in an outcry from the scientific community, citing a violation of Colquhoun's academic freedom. Grant ultimately reconsidered his decision and on 13 June 2007, he and Colquhoun released a joint statement that Colquhoun's website would be reinstated with some modifications effected on advice of counsel. [46] By that time, the web pages had been moved to a proper blog and never did return to the UCL server.

Alternative medicine and the government

Colquhoun was a member of the Conduct and Competence Committee of the Complementary and Natural Healthcare Council (CNHC), a regulatory body for alternative medicine in the UK. Colquhoun has stated he was surprised at being accepted for the position. However, he was dismissed in August 2010. [47]

Colquhoun continues to write on the danger of the alternative medicine industry using government regulation for its own ends. In a 2012 article from the Scottish Universities Medical Journal, he wrote: [48]

There are various levels of regulation. The "highest" level is the statutory regulation of osteopathy and chiropractic. The General Chiropractic Council (GCC) has exactly the same legal status as the General Medical Council (GMC). This ludicrous state of affairs arose because nobody in John Major's government had enough scientific knowledge to realise that chiropractic, and some parts of osteopathy, are pure quackery. The problem is that organisations like the GCC function more to promote their discipline rather than regulate them.

Awards and honours

Colquhoun was elected a Fellow of the Royal Society (FRS) in 1985 [6] [1] and awarded the Humboldt Prize in 1990.

Personal life

In 1976, he married Margaret Ann Boultwood. They have a son and two granddaughters.

Outside academia, Colquhoun has enjoyed (in chronological order) boxing, sailing (21 ft, and later 31 ft sloops), flying light aircraft, long-distance running (10 km, half-marathon and marathon), and mountain walking. [49] In 1988 he did the London marathon in 3 hours 57 minutes. For his 65th birthday, in 2001, he walked across the Alps (Oberstdorf, Germany, to Merano, Italy). [50]

Related Research Articles

<span class="mw-page-title-main">Ion channel</span> Pore-forming membrane protein

Ion channels are pore-forming membrane proteins that allow ions to pass through the channel pore. Their functions include establishing a resting membrane potential, shaping action potentials and other electrical signals by gating the flow of ions across the cell membrane, controlling the flow of ions across secretory and epithelial cells, and regulating cell volume. Ion channels are present in the membranes of all cells. Ion channels are one of the two classes of ionophoric proteins, the other being ion transporters.

<span class="mw-page-title-main">Agonist</span> Chemical which binds to and activates a biochemical receptor

An agonist is a chemical that activates a receptor to produce a biological response. Receptors are cellular proteins whose activation causes the cell to modify what it is currently doing. In contrast, an antagonist blocks the action of the agonist, while an inverse agonist causes an action opposite to that of the agonist.

<span class="mw-page-title-main">Cannabinoid receptor</span> Group of receptors to cannabinoid compounds

Cannabinoid receptors, located throughout the body, are part of the endocannabinoid system of vertebrates– a class of cell membrane receptors in the G protein-coupled receptor superfamily. As is typical of G protein-coupled receptors, the cannabinoid receptors contain seven transmembrane spanning domains. Cannabinoid receptors are activated by three major groups of ligands: endocannabinoids; phytocannabinoids ; and synthetic cannabinoids. All endocannabinoids and phytocannabinoids are lipophilic.

<span class="mw-page-title-main">Patch clamp</span> Laboratory technique in electrophysiology

The patch clamp technique is a laboratory technique in electrophysiology used to study ionic currents in individual isolated living cells, tissue sections, or patches of cell membrane. The technique is especially useful in the study of excitable cells such as neurons, cardiomyocytes, muscle fibers, and pancreatic beta cells, and can also be applied to the study of bacterial ion channels in specially prepared giant spheroplasts.

<span class="mw-page-title-main">Opioid receptor</span> Group of biological receptors

Opioid receptors are a group of inhibitory G protein-coupled receptors with opioids as ligands. The endogenous opioids are dynorphins, enkephalins, endorphins, endomorphins and nociceptin. The opioid receptors are ~40% identical to somatostatin receptors (SSTRs). Opioid receptors are distributed widely in the brain, in the spinal cord, on peripheral neurons, and digestive tract.

<span class="mw-page-title-main">Nicotinic acetylcholine receptor</span> Acetylcholine receptors named for their selective binding of nicotine

Nicotinic acetylcholine receptors, or nAChRs, are receptor polypeptides that respond to the neurotransmitter acetylcholine. Nicotinic receptors also respond to drugs such as the agonist nicotine. They are found in the central and peripheral nervous system, muscle, and many other tissues of many organisms. At the neuromuscular junction they are the primary receptor in muscle for motor nerve-muscle communication that controls muscle contraction. In the peripheral nervous system: (1) they transmit outgoing signals from the presynaptic to the postsynaptic cells within the sympathetic and parasympathetic nervous system, and (2) they are the receptors found on skeletal muscle that receive acetylcholine released to signal for muscular contraction. In the immune system, nAChRs regulate inflammatory processes and signal through distinct intracellular pathways. In insects, the cholinergic system is limited to the central nervous system.

Efficacy is the ability to perform a task to a satisfactory or expected degree. The word comes from the same roots as effectiveness, and it has often been used synonymously, although in pharmacology a distinction is now often made between efficacy and effectiveness.

<span class="mw-page-title-main">Voltage-gated ion channel</span> Type of ion channel transmembrane protein

Voltage-gated ion channels are a class of transmembrane proteins that form ion channels that are activated by changes in the electrical membrane potential near the channel. The membrane potential alters the conformation of the channel proteins, regulating their opening and closing. Cell membranes are generally impermeable to ions, thus they must diffuse through the membrane through transmembrane protein channels. They have a crucial role in excitable cells such as neuronal and muscle tissues, allowing a rapid and co-ordinated depolarization in response to triggering voltage change. Found along the axon and at the synapse, voltage-gated ion channels directionally propagate electrical signals. Voltage-gated ion-channels are usually ion-specific, and channels specific to sodium (Na+), potassium (K+), calcium (Ca2+), and chloride (Cl−) ions have been identified. The opening and closing of the channels are triggered by changing ion concentration, and hence charge gradient, between the sides of the cell membrane.

<span class="mw-page-title-main">Ligand-gated ion channel</span> Type of ion channel transmembrane protein

Ligand-gated ion channels (LICs, LGIC), also commonly referred to as ionotropic receptors, are a group of transmembrane ion-channel proteins which open to allow ions such as Na+, K+, Ca2+, and/or Cl− to pass through the membrane in response to the binding of a chemical messenger (i.e. a ligand), such as a neurotransmitter.

<span class="mw-page-title-main">Ligand (biochemistry)</span> Substance that forms a complex with a biomolecule

In biochemistry and pharmacology, a ligand is a substance that forms a complex with a biomolecule to serve a biological purpose. The etymology stems from Latin ligare, which means 'to bind'. In protein-ligand binding, the ligand is usually a molecule which produces a signal by binding to a site on a target protein. The binding typically results in a change of conformational isomerism (conformation) of the target protein. In DNA-ligand binding studies, the ligand can be a small molecule, ion, or protein which binds to the DNA double helix. The relationship between ligand and binding partner is a function of charge, hydrophobicity, and molecular structure.

<span class="mw-page-title-main">L-type calcium channel</span> Family of transport proteins

The L-type calcium channel is part of the high-voltage activated family of voltage-dependent calcium channel. "L" stands for long-lasting referring to the length of activation. This channel has four isoforms: Cav1.1, Cav1.2, Cav1.3, and Cav1.4.

<span class="mw-page-title-main">MCOLN1</span> Protein-coding gene in the species Homo sapiens

Mucolipin-1 also known as TRPML1 is a protein that in humans is encoded by the MCOLN1 gene. It is a member of the small family of the TRPML channels, a subgroup of the large protein family of TRP ion channels.

<span class="mw-page-title-main">TRPM5</span> Protein-coding gene in the species Homo sapiens

Transient receptor potential cation channel subfamily M member 5 (TRPM5), also known as long transient receptor potential channel 5 is a protein that in humans is encoded by the TRPM5 gene.

<span class="mw-page-title-main">TRPM3</span> Protein-coding gene in the species Homo sapiens

Transient receptor potential cation channel subfamily M member 3 is a protein that in humans is encoded by the TRPM3 gene.

Receptor theory is the application of receptor models to explain drug behavior. Pharmacological receptor models preceded accurate knowledge of receptors by many years. John Newport Langley and Paul Ehrlich introduced the concept that receptors can mediate drug action at the beginning of the 20th century. Alfred Joseph Clark was the first to quantify drug-induced biological responses. So far, nearly all of the quantitative theoretical modelling of receptor function has centred on ligand-gated ion channels and G protein-coupled receptors.

<span class="mw-page-title-main">Two-state trajectory</span>

A two-state trajectory is a dynamical signal that fluctuates between two distinct values: ON and OFF, open and closed, , etc. Mathematically, the signal has, for every either the value or .

<span class="mw-page-title-main">David Julius</span> American physiologist and Nobel laureate 2021

David Jay Julius is an American physiologist and Nobel Prize laureate known for his work on molecular mechanisms of pain sensation and heat, including the characterization of the TRPV1 and TRPM8 receptors that detect capsaicin, menthol, and temperature. He is a professor at the University of California, San Francisco.

<span class="mw-page-title-main">Lucia Sivilotti</span>

Lucia Giulia Sivilotti holds the A.J. Clark Chair of Pharmacology at University College London. Her work is aimed at understanding the functioning of receptors that mediate fast synaptic transmission, and focuses on two classes of ion channels in the nicotinic superfamily, nicotinic and glycine receptors.

The Department of Pharmacology at the University College London, the first of its kind in England, was founded in 1905 and remained in existence until 2007.

Stephanie Schorge is a Professor of Neuroscience in the Department of Neuroscience, Physiology and Pharmacology at University College London. She is known for her research into mutations that cause neurological diseases.

References

  1. 1 2 3 Anon (2015). "Colquhoun, Prof. David" . Who's Who (online Oxford University Press  ed.). A & C Black. doi:10.1093/ww/9780199540884.013.U11583.(Subscription or UK public library membership required.)
  2. 1 2 3 "David Colquhoun's Improbable Science: Truth, falsehood and evidence, investigations of dubious and dishonest science". Archived from the original on 2 March 2013.
  3. 1 2 3 4 Colquhoun, David (2019). "The False Positive Risk: A Proposal Concerning What to Do About p-Values". The American Statistician. 73 (Sup 1): 192–201. arXiv: 1802.04888 . doi:10.1080/00031305.2018.1529622. S2CID   85530643.
  4. 1 2 David Colquhoun publications indexed by Google Scholar
  5. ↑ "UCL Pharmacology: Prof. David Colquhoun". University College London . 14 February 2019.
  6. 1 2 "Professor David Colquhoun FRS". London: Royal Society. Archived from the original on 17 November 2015.
  7. 1 2 "An Uncommon Scientist with a lot of Common Sense" (PDF). University College London.{{cite journal}}: Cite journal requires |journal= (help)
  8. ↑ Colquhoun, David (1964). "The characterization and adsorption of sensitizing antibodies".{{cite journal}}: Cite journal requires |journal= (help)
  9. ↑ Colquhoun, David (1971). Lectures on biostatistics: an introduction to statistics with applications in biology and medicine. Oxford: Clarendon Press. ISBN   978-0-19-854119-6.
  10. ↑ "Scholars: David Colquhoun" (PDF). University College London.{{cite journal}}: Cite journal requires |journal= (help)
  11. 1 2 Colquhoun, D.; Hatton, C. J.; Hawkes, A. G. (2003). "The quality of maximum likelihood estimates of ion channel rate constants". The Journal of Physiology. 547 (3): 699–728. doi:10.1113/jphysiol.2002.034165. PMC   2342730 . PMID   12562901.
  12. ↑ Colquhoun, D.; Hawkes, A. G. (1977). "Relaxation and Fluctuations of Membrane Currents that Flow through Drug-Operated Channels". Proceedings of the Royal Society B: Biological Sciences. 199 (1135): 231–262. Bibcode:1977RSPSB.199..231C. doi:10.1098/rspb.1977.0137. PMID   22856. S2CID   6060354.
  13. ↑ Colquhoun, D.; Sakmann, B. (1981). "Fluctuations in the microsecond time range of the current through single acetylcholine receptor ion channels". Nature. 294 (5840): 464–466. Bibcode:1981Natur.294..464C. doi:10.1038/294464a0. PMID   6273743. S2CID   4353962.
  14. ↑ Colquhoun, D.; Sakmann, B. (1985). "Fast events in single-channel currents activated by acetylcholine and its analogues at the frog muscle end-plate". The Journal of Physiology. 369: 501–557. doi:10.1113/jphysiol.1985.sp015912. PMC   1192660 . PMID   2419552.
  15. ↑ Colquhoun, D. (1998). "Binding, gating, affinity and efficacy: The interpretation of structure-activity relationships for agonists and of the effects of mutating receptors". British Journal of Pharmacology. 125 (5): 923–947. doi:10.1038/sj.bjp.0702164. PMC   1565672 . PMID   9846630.
  16. ↑ Colquhoun D (1987). Affinity, efficacy and receptor classification: is the classical theory still useful? In Perspectives on hormone receptor classification, eds. Black JW, Jenkinson DH, & Gerskowitch VP, pp. 103–114. Alan R. Liss Inc., New York.
  17. ↑ Classical Perspectives, "Classical Perspectives are commentaries on 'classic' articles in The Journal that have stimulated new lines of research and continue to be highly cited. The articles are commissioned from acknowledged experts in the area covered by the article and should indicate how the article has contributed to current developments in the field." The Journal of Physiology
  18. ↑ Colquhoun, D. (2007). "What have we learned from single ion channels?". The Journal of Physiology. 581 (2): 425–427. doi:10.1113/jphysiol.2007.131656. PMC   2075201 . PMID   17363381.
  19. ↑ Colquhoun, D.; Hawkes, A. G. (1982). "On the Stochastic Properties of Bursts of Single Ion Channel Openings and of Clusters of Bursts". Philosophical Transactions of the Royal Society B: Biological Sciences. 300 (1098): 1–59. Bibcode:1982RSPTB.300....1C. doi: 10.1098/rstb.1982.0156 . PMID   6131450.
  20. ↑ UCL's workshop Analysis and interpretation of single ion channel records and macroscopic currents using matrix methods.
  21. ↑ Wyllie, D. J. A.; Behe, P.; Colquhoun, D. (1998). "Single-channel activations and concentration jumps: Comparison of recombinant NR1a/NR2A and NR1a/NR2D NMDA receptors". The Journal of Physiology. 510 (Pt 1): 1–18. doi:10.1111/j.1469-7793.1998.001bz.x. PMC   2231013 . PMID   9625862.
  22. ↑ Hawkes, A. G.; Jalali, A.; Colquhoun, D. (1990). "The Distributions of the Apparent Open Times and Shut Times in a Single Channel Record when Brief Events Cannot Be Detected". Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences. 332 (1627): 511–538. Bibcode:1990RSPTA.332..511H. doi:10.1098/rsta.1990.0129. S2CID   122883551.
  23. ↑ Colquhoun, D.; Jalali, A.; Hawkes, A.G. (1992). "Asymptotic distributions of apparent open times and shut times in a single channel record allowing for the omission of brief events". Philosophical Transactions of the Royal Society of London B. 337 (1282): 383–404. Bibcode:1992RSPTB.337..383H. doi:10.1098/rstb.1992.0116. PMID   1279733.
  24. ↑ Colquhoun, D.; Hawkes, A. G.; Srodzinski, K. (1996). "Joint Distributions of Apparent Open and Shut Times of Single-Ion Channels and Maximum Likelihood Fitting of Mechanisms". Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences. 354 (1718): 2555–2590. Bibcode:1996RSPTA.354.2555C. doi:10.1098/rsta.1996.0115. S2CID   118010415.
  25. ↑ Sivilotti, Lucia (10 March 2011). "Programs description". OneMol.org.uk.
  26. ↑ Castillo, J. D.; Katz, B. (1957). "Interaction at End-Plate Receptors between Different Choline Derivatives". Proceedings of the Royal Society B: Biological Sciences. 146 (924): 369–381. Bibcode:1957RSPSB.146..369C. doi:10.1098/rspb.1957.0018. PMID   13431862. S2CID   6302752.
  27. ↑ Burzomato, V.; Beato, M.; Groot-Kormelink, P. J.; Colquhoun, D.; Sivilotti, L. G. (2004). "Single-Channel Behavior of Heteromeric 1 Glycine Receptors: An Attempt to Detect a Conformational Change before the Channel Opens". Journal of Neuroscience. 24 (48): 10924–10940. doi: 10.1523/JNEUROSCI.3424-04.2004 . PMC   6730200 . PMID   15574743.
  28. ↑ Lape, R.; Colquhoun, D.; Sivilotti, L. G. (2008). "On the nature of partial agonism in the nicotinic receptor superfamily". Nature. 454 (7205): 722–727. Bibcode:2008Natur.454..722L. doi:10.1038/nature07139. PMC   2629928 . PMID   18633353.
  29. ↑ Mukhtasimova, N.; Lee, W. Y.; Wang, H. L.; Sine, S. M. (2009). "Detection and trapping of intermediate states priming nicotinic receptor channel opening". Nature. 459 (7245): 451–454. Bibcode:2009Natur.459..451M. doi:10.1038/nature07923. PMC   2712348 . PMID   19339970.
  30. ↑ Colquhoun, David (2015). "An investigation of the false discovery rate and the misinterpretation of p-values". Royal Society Open Science. 1 (3): 140216. arXiv: 1407.5296 . Bibcode:2014RSOS....140216C. doi:10.1098/rsos.140216. PMC   4448847 . PMID   26064558.
  31. ↑ Colquhoun, David. "The problem with p-values". Aeon Magazine. Retrieved 11 December 2016.
  32. 1 2 3 Colquhoun, David (2017). "The reproducibility of research and the misinterpretation of p-values". Royal Society Open Science. 4 (12): 171085. doi:10.1098/rsos.171085. PMC   5750014 . PMID   29308247.
  33. ↑ Longstaff, Colin; Colquhoun, David. "Calculator for false positive risk (FPR)". UCL.
  34. 1 2 Colquhoun, D. (2007). "Science degrees without the science". Nature. 446 (7134): 373–374. Bibcode:2007Natur.446..373C. doi:10.1038/446373a. PMID   17377563. S2CID   29071826.
  35. ↑ Colquhoun, D. (2009). "The arrogance of trying to sum up abilities in a number". Nature. 458 (7235): 145. Bibcode:2009Natur.458..145C. doi: 10.1038/458145c . PMID   19279607.
  36. ↑ Colquhoun, D. (2003). "Challenging the tyranny of impact factors". Nature. 423 (6939): 479. Bibcode:2003Natur.423..479C. doi: 10.1038/423479a . PMID   12774093.
  37. ↑ Colquhoun, David (15 August 2007). "The age of endarkenment". The Guardian.
  38. ↑ "Rise in applications for 'soft' subjects panned as traditional courses lose out". 27 July 2007.
  39. ↑ Colquhoun, David (2007). "How to get good science". Physiology News. 69: 12–14.
  40. ↑ Information Tribunal appeal judgement
  41. ↑ Colquhoun's response to judgement
  42. ↑ Appleyard, Bryan (22 February 2009). "A guide to the 100 best blogs: part II". The Sunday Times. Archived from the original on 28 May 2015. Retrieved 5 February 2013.
  43. ↑ UK Science Blog. Good Thinking Society.
  44. ↑ Colquhoun, David (1 December 2014). "Publish and perish at Imperial College London: the death of Stefan Grimm". DCscience.net. Retrieved 25 September 2015.
  45. ↑ "Freedom of speech and litigious herbalists".
  46. ↑ "Joint Statement by Professor Colquhoun and UCL". University College London. 12 June 2007.{{cite journal}}: Cite journal requires |journal= (help)
  47. ↑ "Why the Complementary and Natural Healthcare Council (CNHC) can't succeed (in which DC gets fired)". 11 August 2010.
  48. ↑ Colquhoun, David (2012). "Regulation of Alternative Medicine- why it doesn't work" (PDF). Scottish Universities Medical Journal.
  49. ↑ "DC's sports". David Colquhoun. Retrieved 3 December 2019.
  50. ↑ "Walk across the Alps, 2001". David Colquhoun. Retrieved 2 June 2019.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.